Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke

Overview of attention for article published in Stroke, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 22 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 89 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 23 X posts from 22 X users, with an upper bound of 84,396 followers.

RT @amrsarrajMD: AcT/TASTE-A:non-inferiority/⬇️ core (MSU delivery). Contrasting in NOR-TEST2:⬆️mortality/ICH in severe strokes, plausibly…

06 May 2022

Reply Repost Favourite

AcT/TASTE-A:non-inferiority/⬇️ core (MSU delivery). Contrasting in NOR-TEST2:⬆️mortality/ICH in severe strokes, plausibly due to higher dose/lack of adaptive randomization—>baseline imbalances. NOR-TEST1(2019 subanalysis):⬆️mortality in mod/severe strok

05 May 2022

Reply Repost Favourite

Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke | Stroke https://t.co/uewncrU91l

27 Oct 2019

Reply Repost Favourite

RT @Bergen_Stroke: Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke | Stroke https://t.co/mSzMtYWcSb

16 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.